BLKB vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

BLKB

60.4
AI Score
VS
BLKB Wins

DBD

38.6
AI Score

Investment Advisor Scores

BLKB

60score
Recommendation
HOLD

DBD

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BLKB DBD Winner
Forward P/E 7.6687 12.1655 BLKB
PEG Ratio 0.4537 0 Tie
Revenue Growth 3.0% 1.7% BLKB
Earnings Growth 43.6% 34.2% BLKB
Tradestie Score 60.4/100 38.6/100 BLKB
Profit Margin 13.1% 2.9% BLKB
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY BLKB

Relative Price Performance (Last 90 Days)

BLKB 1M: -11.8% · 3M: +43.1% DBD 1M: -4.2% · 3M: -23.0%

Current Technical Phase

BLKB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.8 · Price: $41.88

DBD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $64.81

Fundamentals Snapshot

Metric BLKB DBD
Market Cap — —
Forward P/E 7.1 9.0
Trailing P/E 13.0 20.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.3%
Operating Margin 0.2% 0.1%
EPS 3.20 3.02
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BLKB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.